Net income AbbVie Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income AbbVie Inc. is 766 000 000 $ Current assets AbbVie Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets AbbVie Inc. is 25 999 000 000 $ Total assets AbbVie Inc. refers to the total amount of assets owned by a person or entity. Total assets AbbVie Inc. is 147 972 000 000 $
|
|
30/06/2021
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
|
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
|
9 461 000 000 $ |
8 818 000 000 $ |
10 448 000 000 $ |
7 874 000 000 $ |
|
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
|
4 498 000 000 $ |
4 192 000 000 $ |
3 410 000 000 $ |
5 028 000 000 $ |
|
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
|
13 959 000 000 $ |
13 010 000 000 $ |
13 858 000 000 $ |
12 902 000 000 $ |
|
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
|
- |
- |
- |
- |
|
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
|
4 696 000 000 $ |
4 346 000 000 $ |
5 528 000 000 $ |
3 547 000 000 $ |
|
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
|
766 000 000 $ |
3 553 000 000 $ |
36 000 000 $ |
2 308 000 000 $ |
|
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
|
1 784 000 000 $ |
1 731 000 000 $ |
1 821 000 000 $ |
1 575 000 000 $ |
|
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
|
9 263 000 000 $ |
8 664 000 000 $ |
8 330 000 000 $ |
9 355 000 000 $ |
|
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
|
25 999 000 000 $ |
26 569 000 000 $ |
24 173 000 000 $ |
23 009 000 000 $ |
|
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
|
147 972 000 000 $ |
150 501 000 000 $ |
150 565 000 000 $ |
149 621 000 000 $ |
|
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
|
8 546 000 000 $ |
9 755 000 000 $ |
8 449 000 000 $ |
7 890 000 000 $ |
|
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
|
- |
- |
- |
- |
|
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
|
- |
- |
- |
- |
|
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
|
- |
- |
- |
- |
|
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
|
- |
- |
- |
- |
|
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
|
12 569 000 000 $ |
13 710 000 000 $ |
13 076 000 000 $ |
15 270 000 000 $ |
|
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
|
- |
- |
- |
- |
